Kyphoplasty Market Thumbnail Image

2022

Kyphoplasty Market

Kyphoplasty Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Indication, by End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

LS : Medical Devices & Supplies

Select an option
Author's: Shraddha Mali| Madhuvanti Balkrishna Divekar | Roshan Deshmukh
Publish Date:

Get Sample to Email

Kyphoplasty Market Research, 2031

The global kyphoplasty market was valued at $632.45 million in 2021, and is projected to reach $1.2 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. A surgical treatment called kyphoplasty is used to widen and stabilize spinal compression fractures. It involves injecting a specific cement into the spine and creating space for the procedure with a balloon-like device. Kyphoplasty is a kind of vertebroplasty that restores the height of a damaged vertebra while also reducing pain. It is one of the treatments for vertebral body compression fractures, which are tiny breaks in the thick bone mass that makes up the front segment of the spinal cord.

Kyphoplasty Market, Kyphoplasty Market size, Kyphoplasty Market share, Kyphoplasty Market trends, Kyphoplasty Market growth, Kyphoplasty Market analysis, Kyphoplasty Market forecast, Kyphoplasty Market opportunity

Patients who are not improving with their current therapy and are in danger of significant deterioration might consider kyphoplasty. It's a pretty particular treatment that's only used in patients who've suffered a vertebral fracture, and not for other causes such as disc rupture or arthritis. Untreated vertebral compression fractures can have substantial clinical effects and have a considerable influence on the quality of life of patients as well as caretakers. Because non-surgical treatment of these fractures is ineffective, kyphoplasty operations for fracture stabilization and pain control are becoming more common in medical practice.

The drivers contributing to the growth of the kyphoplasty market include increase in elderly population, increase in incidence of osteoporosis and arthritis, increase in frequency of spine problems, and increase in patient knowledge regarding innovations in spine procedures. Furthermore, the market's push toward minimally invasive spine operations is a crucial trend that is expected to drive the development throughout the forecast period. Risks associated with post-surgical complications are projected to stifle market expansion, particularly poor reimbursement circumstances.

The kyphoplasty market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is categorized into kyphoplasty systems and accessories. By indication, it is divided into osteoporosis and others. By end user, it is segmented into hospitals & clinics and ambulatory surgical centers.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment Review

Depending on product, the accessories segment held the largest share in the global market in 2021 and is expected to remain dominant during the forecast period, owing to increase in demand for bone cements and biopsy kits due to surge in vertebral related cancer cases. The kyphoplasty systems segment is expected to witness highest CAGR of 6.6% during the kyphoplasty market forecast period, owing to various development and launch of products such as the balloon inflation devices and bone access devices.

Kyphoplasty Market by Product

Depending on indication, the osteoporosis segment held the largest kyphoplasty market share in the global market in 2021 with and is expected to remain dominant during the forecast period, owing to increase in geriatric population and rise in osteoporosis cases globally. The others segment is expected to witness highest kyphoplasty market growth of 7.2% during the forecast period owing to surge in road accidents, sports injuries and cancer cases among the population.

Kyphoplasty Market by Indication

Depending on end user, the hospitals & clinics segment held the largest kyphoplasty market size in 2021 with and is expected to remain dominant during the forecast period, owing to increase in number of hospital admissions for vertebral compression fractures and accidental injuries to spinal cord. The ambulatory surgical centers segment is expected to witness highest CAGR of 7.2% during the forecast period owing to surge in osteoporosis diagnosis and demand for ASCs owing to their specific care and comfortable settings for elderly.

Kyphoplasty Market by End User

Region wise, North America is expected to account for the largest kyphoplasty market size, owing to established robust infrastructure of hospitals, advanced technology and availability of key players across the region, followed by Europe, Asia-Pacific, and LAMEA. Asia-Pacific is expected to register the fastest CAGR during the forecast period, due to increase in geriatric population, rapid development in healthcare technology, and increase in public–private investment. Moreover, India and China are expected to offer lucrative kyphoplasty market opportunity and are set to witness growth at high CAGR in the kyphoplasty market of Asia-Pacific.

Kyphoplasty Market by Region

The key players operating in the global kyphoplasty industry are Alphatec Holdings Inc., Benvenue Medical Inc., Globus Medical Inc., IZI Medical Products, Johnson and Johnson, Medtronic Plc., Merit Medicals Systems, Stryker Corporation, Seawon Meditech and Zimmer Biomet Holdings, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the kyphoplasty market analysis from 2021 to 2031 to identify the prevailing kyphoplasty market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the kyphoplasty market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global kyphoplasty market trends, key players, market segments, application areas, and market growth strategies.

Kyphoplasty Market Report Highlights

Aspects Details
icon_5
By Product
  • Kyphoplasty Systems
  • Accessories
icon_6
By Indication
  • Osteoporosis
  • Others
icon_7
By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
icon_9
Key Market Players

Medtronic, Alphatec Holdings TNC, Merit Medicals Systems, IZI Medica Products, Swawon Meditech, Jhonson and Jhonson, Stryker, Globul Medical Inc, Benvenue Medical Inc

Analyst Review

This section provides opinions of top level CXOs in the global kyphoplasty market. According to the insights of CXOs, leading companies in the market, development of advanced and reliable kyphoplasty systems has led to extensive number of applications of this technique. Increase in demand for minimally invasive procedures and better healthcare services are also expected to propel the mass kyphoplasty market.

The kyphoplasty industry holds a high potential, owing to innovative concepts and multidisciplinary expertise demand for new technological advancements in the creation of kyphoplasty cements. The recommendations for them are anticipated to expand with the introduction of new biodegradable and mechanically matched bone cements. Polymethylmethacrylate one of them is employed in modern procedures such as percutaneous vertebroplasty and kyphoplasty, and it plays an important part in the success of total joint replacement. Increase in use of kyphoplasty techniques by researchers have led to an enhancement of these instruments capable of pushing robotic surgery boundaries to address an ever-growing range of spinal challenges.

Author Name(s) : Shraddha Mali| Madhuvanti Balkrishna Divekar | Roshan Deshmukh
Frequently Asked Questions?

The global kyphoplasty market was valued at $632.45 million in 2021, and is estimated to reach $1,154.82 million by 2031

Trends of the kyphoplasty market include increase in elderly population, increase in incidence of osteoporosis and arthritis, increase in frequency of spine problems, and increase in patient knowledge regarding innovations in spine procedures.

Osteoporosis is the leading application of Kyphoplasty Market

North America is the largest regional market for Kyphoplasty

The key players to hold the market share in the global kyphoplasty market are Alphatec Holdings Inc., Benvenue Medical Inc., Globus Medical Inc., IZI Medical Products, Johnson and Johnson, Medtronic Plc., Merit Medicals Systems, Stryker Corporation, Seawon Meditech and Zimmer Biomet Holdings, Inc.

Loading Table Of Content...

Kyphoplasty Market

Global Opportunity Analysis and Industry Forecast, 2021-2031